Australia markets closed

Mindset Pharma Inc. (MSSTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.3307-0.0163 (-4.70%)
At close: 03:36PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.3470
Open0.3535
BidN/A x N/A
AskN/A x N/A
Day's range0.3215 - 0.3588
52-week range0.2500 - 0.8416
Volume91,759
Avg. volume25,957
Market cap30.278M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.2090
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Mindset Pharma Progresses Plans for Clinical Trials of its Advanced Pre-Clinical Psychedelic, MSP-1014

    TORONTO, May 12, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today announced that it is making headway in progressing its Family 1 lead clinical candidate, MSP-1014, towards clinical trials. Recently, the Company engaged a UK-based C

  • GlobeNewswire

    Mindset Pharma to Participate in Upcoming Conferences in May 2022

    TORONTO, May 04, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today announced that James Lanthier, CEO, and Joseph Araujo, CSO of Mindset, will participate in two upcoming conferences: The 2nd Annual Psychedelic Therapeutics & Drug De

  • GlobeNewswire

    KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand Viewing

    NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the April 27th and 28th KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing. REGISTER OR LOGIN NOW AT: https://bit.ly/3OGHgD4 The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section. Comp